A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden
- DOI
- 10.1158/2767-9764.crc-26-0210
- Published
- 2026-09-01
- Container
- Cancer Research Communications
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/2767-9764.crc-26-0210,
title = {A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden},
author = {Christine Federspiel Secher and Martin Højgaard and Iben Spanggaard and Ane Yde Schmidt and Yuliu Guo and Luca Robinson and Daniela De Zio and Linea N. Toksvang and Frederik Otzen Bagger and Kjeld Schmiegelow and Kristoffer S. Rohrberg},
year = {2026},
journal = {Cancer Research Communications},
doi = {10.1158/2767-9764.crc-26-0210},
url = {https://doi.org/10.1158/2767-9764.crc-26-0210}
}RIS
TY - JOUR TI - A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden AU - Christine Federspiel Secher AU - Martin Højgaard AU - Iben Spanggaard AU - Ane Yde Schmidt AU - Yuliu Guo AU - Luca Robinson AU - Daniela De Zio AU - Linea N. Toksvang AU - Frederik Otzen Bagger AU - Kjeld Schmiegelow AU - Kristoffer S. Rohrberg PY - 2026 JO - Cancer Research Communications DO - 10.1158/2767-9764.crc-26-0210 UR - https://doi.org/10.1158/2767-9764.crc-26-0210 ER -
APA
Secher, C. F., Højgaard, M., Spanggaard, I., Schmidt, A. Y., Guo, Y., Robinson, L., Zio, D. D., Toksvang, L. N., Bagger, F. O., Schmiegelow, K., & Rohrberg, K. S. (2026). A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden. Cancer Research Communications. https://doi.org/10.1158/2767-9764.crc-26-0210
Source records
- crossref · retrieved 2026-11-10T16:36:13.296Z